Neurostimulation Devices Market To Reach USD 12.7 Billion By 2026 | Reports And DataHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Neurostimulation Devices Market To Reach USD 12.7 Billion By 2026 | Reports And DataGlobeNewswireJanuary 8, 2020ReblogShareTweetShareNeurostimulation Devices Market Size – USD 4.98 Billion in 2018, CAGR of 12.4%, Neurostimulation Devices Industry Trends – Product launches and research for advanced Neurostimulation DevicesNew York, Jan. 08, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Neurostimulation Devices market was valued at USD 4.98 Billion in 2018 and is expected to reach USD 12.7 Billion by the year 2026, at a CAGR of 12.4 %. Neurostimulation Devices - Neurostimulator or Neurostimulation are equipment that is used for neuromodulation. The process of making use of an implantable medical device to alter and modulate neural activities for therapeutic purposes is called neuromodulation. The recent emergence of Neurostimulation Devices as a neural activity modulator is a major disruptive finding in the healthcare sector. In line with this, market leaders, as well as emerging players, are developing mechanisms that can be used for neural activities modulation. For instance, Medtronic plc US-based medical device company launched EnterraII gastric neurostimulator, a programmable device that generates mild electrical pulses for gastric electrical stimulation to treat chronic, intractable nausea and vomiting due to gastroparesis.Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/2303Rising prevalence of chronic diseases and lifestyle health disorders, unmet needs of patients are pushing the technological development, significant focus of healthcare companies on development of novel mechanisms, upcoming patent expiry, availability of private as well public funds for research, and affirmative regulatory scenario all over the globe, are some of the notable factors boosting market growth in the industry. According to the American Academy of Neurology, stroke is listed as the third leading cause of death in U.S., with Alzheimer’s being ranked as the sixth leading cause of death. Statistics from the same source indicate that Parkinson’s affects nearly 1 million Americans annually with at least a minimum of 60,000 new cases that are reported annually. However, associated adverse effects and availability of advanced alternative options are the major hindrances for Neurostimulation devices market growth during 2019-2026.Further key findings from the report suggestNeurostimulation Devices market is growing at a CAGR of 13.6% in the Asia Pacific, followed by North America and Europe, with 12.3 % and 12.1% CAGR, respectively. Rising chronic disease prevalence across the globe is the prominent factor to accelerate the Neurostimulation Devices market growth during forecast period across all regionsAs of 2018, Spinal Cord Stimulators is the dominating Neurostimulation Devices, which holds 35.5% of the global market. European regional market is the chief revenue-generating source for this product segment, followed by North America, Asia-Pacific, and other regionsSacral Nerve Stimulators is expected to be the fastest-growing market segment during the forecast period 2019-2026, with a CAGR of 13.2%. However, associated stringent government regulation is a major challenge for the Neurostimulation Devices market growth of this market segmentPain Management application type segment was valued at USD 2.03 billion in 2018 and is expected to reach USD 5.3 billion by 2026The Asia Pacific is expected to account for 19.4% of the global Neurostimulation Devices market. Developing nations such as China and India are likely to observe high growthAssociated adverse effects related to Neurostimulation Devices and Availability of external substitutes is expected to hinder the market growth during the forecast periodKey participants in Neurostimulation Devices include Medtronic PLC, BioControl Medical, St. Jude Medical, Spinal Modulation, Boston Scientific Corp., Synapse Biomedical Inc., Cochlear, Cyberonics, Inc., and Nevro Corp. To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/neurostimulation-devices-marketSegments covered in the report:This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2026. For the purpose of this report, Reports and Data has segmented the Neurostimulation Devices market on the basis of type, Product type, Application type, end use, and region:                   Product Type (Revenue, USD Million; 2016–2026)Spinal Cord StimulatorsDeep Brain StimulatorsSacral Nerve StimulatorsVagus Nerve StimulatorsGastric Electric StimulatorsApplication Type (Revenue, USD Million; 2016–2026)Pain ManagementEpilepsyEssential TremorUrinary and Fecal IncontinenceDepressionDystoniaGastroparesisParkinson's DiseaseOthersType (Revenue, USD Million; 2016–2026)ImplantableExternalEnd Use (Revenue, USD Million; 2016–2026)Hospitals/ClinicsCognitive Care CentersResearch InstitutesOthersOrder Now: https://www.reportsanddata.com/checkout-form/2303Regional Outlook (Revenue in USD Million; 2016–2026)North America
U.S.
Europe
France UK
Asia Pacific
China India Japan
Latin America
Brazil
Middle East and AfricaBrowse more similar reports on Diagnostics category by Reports And DataPositron Emission Tomography Market - https://www.reportsanddata.com/report-detail/positron-emission-tomography-marketAnatomical Models Market - https://www.reportsanddata.com/report-detail/anatomical-models-marketAbout Reports and DataReports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.Story continuesContact Us:John WatsonHead of Business DevelopmentReports And Data | Web: www.reportsanddata.comDirect Line: +1-212-710-1370E-mail: sales@reportsanddata.comReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextAsian markets slammed again as virus fears cause global turmoilAFPFragile Economic Recovery in India Faces New Risk from VirusBloombergCitigroup, Goldman, JPMorgan Slash Earnings Estimates for StocksBloombergHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloomberg